openPR Logo
Press release

Global Deep Brain Stimulation Devices Market is Anticipated to be Worth US$9.4 bn by the end of 2020

12-26-2017 03:02 PM CET | Health & Medicine

Press release from: Transparency Market Research

Global Deep Brain Stimulation Devices Market is Anticipated

The vendor landscape of the global deep brain stimulation devices market for Parkinson’s disease includes giants such as Boston Scientific, Aleva Neurotherapeutics SA, Medtronic Inc., and St. Jude Medical Inc. The market players are increasingly outsourcing the manufacturing of DBS devices to contract manufacturing organizations (CMOs).

Furthermore, the market players are targeting emerging economies in regions such as Asia Pacific by improving public awareness about Parkinson’s disease, its consequences, treatment options, and associated benefits of DBS devices, a new Transparency Market Research report states. “Improving the product life and reducing the prices of DBS devices would create better prospects for the market players,” a TMR analyst recommends.

Obtain Report Details @ https://www.transparencymarketresearch.com/deep-brain-stimulator-market.html

Geriatric Population Represents Key Target Market for DBS Devices

Rapidly growing geriatric population has led to the high prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, dementia, and others. This is one of the key factors driving the growth of the global DBS devices market for Parkinson’s disease. Neurological disorders are one of the major causes of mortality and are responsible for around 12% of deaths every year across the globe. Parkinson’s disease is the most prevalent neurological disorder after Alzheimer’s disease.

Though drug therapy is termed as the most effective treatment option to control the initial stages of Parkinson’s disease, surgical treatment using DBS devices is effective in the later stages of the disease. Patients and physicians increasingly prefer minimally invasive procedures for the treatment of Parkinson’s disease. The availability of technologically advanced DBS devices, coupled with favorable reimbursement scenario has led to the increased acceptance of DBS devices worldwide.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1435

However, the risks associated with deep brain stimulation procedures might play spoilsport in the growth of the market. The implementation of certain government policies such as the Affordable Care Act in the U.S. would negatively impact the market’s growth during the forecast period. “The presence of a large patient pool across the emerging economies is expected to create new growth opportunities for the market,” a TMR analyst states.

Progressive Increase in New Cases of Parkinson’s Disease Puts New Opportunities in Focus

Among the key regions in the global DBS devices market for Parkinson’s disease, North America has been a major market owing to the growing prevalence of the disease. According to the Parkinson’s Disease Foundation, about 10 mn people worldwide suffer from this condition and over 1 mn of these patients are in the U.S. Around 60,000 new cases of Parkinson’s disease are diagnosed every year in the region. Furthermore, the growing awareness of the disease has propelled the growth of the regional DBS devices market.

Purchase this Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=432

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Deep Brain Stimulation Devices Market is Anticipated to be Worth US$9.4 bn by the end of 2020 here

News-ID: 875936 • Views:

More Releases from Transparency Market Research

Global Galvanized Steel Coil Market for Building Materials Poised to Reach USD 57.2 Bn | Transparency Market Research
Global Galvanized Steel Coil Market for Building Materials Poised to Reach USD 5 …
The global Galvanized Steel Coil Market for Building Materials is entering a high-growth period driven by rapid urbanization, rising investment in infrastructure, sustainability-focused construction practices, and advanced corrosion-resistant technologies. According to the latest industry outlook, the market-valued at USD 32.6 Bn in 2024-is projected to expand at a CAGR of 5.3% from 2025 to 2035, reaching USD 57.2 Bn by 2035. This press release presents a comprehensive analysis of the market,
Global Silage Film Market Set to Reach USD 5.5 Billion by 2034, Driven by Sustainable Agriculture and Rising Livestock Production
Global Silage Film Market Set to Reach USD 5.5 Billion by 2034, Driven by Sustai …
The global agricultural landscape is undergoing a transformative shift as farmers worldwide adopt modern techniques to enhance crop preservation, livestock feed quality, and operational efficiency. One of the key enablers of this transition is the growing use of silage films-high-performance protective coverings used to store and preserve forage. According to the latest industry assessment, the global silage film market, valued at US$ 2.9 Bn in 2023, is projected to expand
Global Canine Atopic Dermatitis Market Set to Surpass USD 431.0 Million by 2035 Amid Rising Pet Ownership and Advancements in Veterinary Dermatology
Global Canine Atopic Dermatitis Market Set to Surpass USD 431.0 Million by 2035 …
The global Canine Atopic Dermatitis Market is poised for strong long-term expansion, projected to grow at a CAGR of 5.8% from 2025 to 2035, increasing from US$ 231.4 Mn in 2024 to more than US$ 431.0 Mn by 2035. Rising cases of allergic skin disorders in dogs, soaring pet adoption rates, and heightened awareness of pet health are collectively shaping the future trajectory of this dynamic industry. Introduction: Canine atopic dermatitis
Global Bio-Based Polyethylene Furanoate (PEF) Market Set for Strong Expansion, Projected to Reach USD 31.4 Million by 2035 | TMR
Global Bio-Based Polyethylene Furanoate (PEF) Market Set for Strong Expansion, P …
The global Bio-Based Polyethylene Furanoate (PEF) Market is gaining remarkable momentum as industries worldwide accelerate the shift toward renewable, recyclable, and low-carbon polymer solutions. According to the latest market assessment, the bio-based PEF industry, valued at US$ 13.4 Mn in 2024, is projected to grow at a CAGR of 8.1% between 2025 and 2035, reaching an estimated US$ 31.4 Mn by 2035. Increasing sustainability requirements, consumer demand for eco-friendly packaging,

All 5 Releases


More Releases for Parkinson’s

Parkinson’s Disease Treatment Market 2021 | Detailed Report
Parkinson’s Disease Treatment Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Parkinsons Disease Treatment Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024082 The report provides a comprehensive analysis of company profiles listed below: - Teva - Roche - Prothena - Acorda
Parkinson’s Disease Treatment Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Parkinson’s Disease Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Parkinson’s Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Parkinson’s Disease Treatment with respect
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent. Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial